The Claim
In older adults undergoing exercise training, once-weekly administration of 6 mg rapamycin attenuates improvements in lower-body strength compared to exercise training alone, although both groups show some degree of functional gain.
What the research says
Challenges is higher
Challenge is ahead, but a single strong supporting study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking a weekly 6 mg dose of rapamycin might actually slow down strength gains in older people who are working out, even though both those on and off the drug get a bit stronger.
See the scientific wording
Once-weekly rapamycin at 6 mg attenuates functional improvements in lower-body strength during exercise training in older adults, despite both groups showing directional gains.
What the research says
2 studiesThe study found that older adults taking weekly rapamycin improved less in leg strength during exercise compared to those on placebo, even though both groups got stronger. This supports the idea that rapamycin may hold back some benefits of exercise.
The study is about the same treatment and people described in the claim, but it hasn’t reported any results yet, so we can’t say if it supports or contradicts the claim.
Related videos
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 2 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.